跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NARCAN NASAL SPRAY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NARCAN NASAL SPRAY
Authorized
STANDARD
NARCAN NASAL SPRAY
emergent operations ireland limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
88bcbfccdae955df
Company
emergent operations ireland limited
Type
Standard
Approval Details
Approval Id
88bcbfccdae955df
Drug Approval Canada Name
NARCAN NASAL SPRAY
Product Name
NARCAN NASAL SPRAY
Status
Marketed
Status Date
2021-03-09
Original Market Date
2017-07-07
Din
02458187
Drug Class
Human
Dosage Form
Spray, Metered Dose
Route Of Administration
Nasal
Schedule
Ethical
Ahfs
28:10.00
Atc Original
V03AB15 NALOXONE
Atc Name
v 03 ab 15
Aig Number
0108981005
Company Name
emergent operations ireland limited
Company Address
6th Earlsfort Terrace, Dublin 2, --, Ireland, D02W773
Active Ingredients
NALOXONE HYDROCHLORIDE
4 MG / 0.1 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
88bcbfccdae955df
Type
Standard
Back to Health Canada Approvals